Cancer

The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds. Read More

Cell surface molecules called integrins have been found to play an important role when cancer metastasizes. Read More

David Gius, M.D., Ph.D., and colleagues are studying an aging-associated protein’s role in the development of breast cancer in older women. (Vanderbilt University/photo by Mary Donaldson) The most common type of breast cancer in older women – estrogen and progesterone receptor (ER/PR) positive breast cancer – has been linked to… Read More

Vanderbilt is using a bold new approach in the fight against cancer; learn how each patient’s genetic make-up is creating the newest weapon against tumors. Plus, the app you need before having a baby, and 365 amazing views of Vandy! [vucastblurb]… Read More

Ezra Fitz (Photo credit: Daniel Dubois, Vanderbilt University) In late January of 2006, I was looking neither at tide pools, nor at stars. I was staring intently – just as I am now, as I’m writing this – into a computer screen, trying to cover a bone-white Word document with… Read More

[vucastblurb]… Read More

Immortality and uncontrolled cell division are the fundamental differences between cancer cells and normal cells. Read More

The South is known for many things: hot, steamy summers, iced tea laced with sugar and friendly people with a tendency to welcome strangers. But beneath the veneer of Southern hospitality and gracious living lurks a silent killer: cancer. Vanderbilt-Ingram Cancer Center researchers have their own name for the southern region of the United States: the "cancer belt." Read More

President George W. Bush has appointed Jennifer A. Pietenpol, director of Vanderbilt-Ingram Cancer Center, to the National Cancer Advisory Board. Pietenpol, the B.F. Byrd Jr. Professor of Oncology at Vanderbilt-Ingram, will serve a six-year term through March 9, 2014. Read More

Vanderbilt-Ingram Cancer Center has been selected as a Blue Distinction Center for Complex and Rare CancersSM by Blue Cross Blue Shield Association, in collaboration with BlueCross BlueShield of Tennessee. Read More

Cancer patients from the Southeastern United States who are treated with the drug cetuximab, known commercially as Erbitux, are far more likely to suffer severe allergic reactions than patients in other regions of the country. Read More

Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center. Read More

Women who receive silicone gel-filled breast implants do not have a higher risk of breast cancer or other cancers and do not experience lower survival rates after breast cancer diagnosis, according to a new report published in the November issue of Annals of Plastic Surgery. This is the first exhaustive review in almost a decade of the health effects of cosmetic breast implants. Read More

Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision. Read More

As many as 30 percent of chemotherapy patients suffer from chemo fog causing moderate cognitive brain impairment. With funding help from athlete and cancer survivor Lance Armstrong, Vanderbilt University Medical Center researchers are studying how to clear chemo fog. Barb Cramer has the story. Read More

The Vanderbilt-Ingram Cancer Center and AstraZeneca have developed a master scientific agreement to streamline and integrate collaborations in basic, translational and clinical cancer research, officials with the company and cancer center announced today. Read More

Earlier this year, with surprisingly little media attention, we celebrated a major milestone in the fight against cancer — for the first time in record-keeping history, the number of American lives lost to cancer declined. Read More

The Vanderbilt Breast Center is offering a new class for breast cancer survivors during or after treatment, using the ancient Chinese practice of Qigong, pronounced "chee gung," to help promote renewal and restoration. Read More

When 24-year-old Charles Dougherty checks into Vanderbilt-Ingram Cancer Center tomorrow, he'll be preparing for a treatment that has never been performed before in an adult patient in Nashville, and will be only the second case in Tennessee history. Read More

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant Read More